Finally, I think in this bill what we see is the power of research and development innovation to unlock future ways of both preventing, screening for, and treating cervical cancer. Because what we see in the detailed provisions, for example, is the fact that we now are moving to screening for HPV, primary screening for the human papilloma virus—forgive me, medical people listening—rather than simply screening for examining cells. That reflects the fact that we now have better research, we have better information about what are the precursors to cervical cancer, but we also know that this bill will accommodate some of the new ways we have of screening that are easier for women, that are better for women, that potentially allow them to feel more mana and dignity in the testing process, and that I really hope—I really hope—will ensure more women do the testing we so need them to do so that they can live good long lives and so that if they have problems, we can catch them as early as possible.